Discordance between Physiology and Imaging Guided PCI in Intermediate Coronary Lesions: Who to trust?

As regards intermediate coronary lesion intervention, physiological assessment is essential for culprit lesion identification and clinical decision making. It has been shown, in a randomized study, that physiology-guided percutaneous coronary intervention (PCI), along with intravascular ultrasound (IVUS), is not inferior for the combined two-year outcome of all-cause death, acute myocardial infarction (AMI), and revascularization.

Currently, the combination of these strategies is considered best practice. However, their discrepancies and clinical implications remain unclear.

The aim of this post-hoc analysis of the FLAVOUR study (Fractional Flow Reserve and Intravascular Ultrasound for Clinical Outcomes in Patients with Intermediate Stenosis) was to evaluate the discrepancy and relevance of physiological assessment in IVUS-guided PCI.

The Primary Endpoint was major adverse cardiovascular events (MACE) incidence, defined as a composite of death, acute myocardial infarction (AMI), and revascularization, at one-year follow-up.

Read also: Edge-to-Edge Repair in Atrial Secondary Tricuspid Regurgitation.

The Secondary Endpoint included angina frequency and quality of life, a per the Seattle Angina Questionnaire. Patients were classified based on IVUS use for PCI guidance (performed vs. deferred PCI) and QFR value, as follows:

Deferred Group: Negative QFR + deferred PCI.

Performed Group: Negative QFR + performed PCI.

Reference Group: Positive QFR + performed PCI.

34.4% of the 784 analyzed patients belonged to the deferred group, 29.3% to the performed group, and 31.5% to the reference group. Mean age was approximately 65, and most participants were male. The most frequently treated coronary artery was the left anterior descending, followed by the right coronary.

Cumulative MACE incidence at two years was 4.5%, 3.9%, and 9.4% for the deferred, performed, and reference groups, respectively (P = 0.019). MACE risk resulted higher among reference group patients vs. the performed group (HR: 2.46; 95% CI: 1.13–5.35; P = 0.023) and the deferred group (HR: 2.17; 95% CI: 1.07–4.38; P = 0.031). 

Read also: Trends in the Treatment of Critical Lower Limb Ischemia.

In patients with negative QFR, there were no prognostic differences between the performed and deferred groups as regards MACE (HR: 0.88; 95% CI: 0.37–2.11; P = 0.779) or AMI (HR: 1.48; 95% CI: 0.49–4.45; P = 0.484), and neither were there differences in secondary end point.

Conclusión 

Angiography-based physiological assessment may provide additional prognostic information in patients undergoing IVUS-guided PCI. IVUS guided PCI may not be beneficial in patients with functionally non-significant lesions. This sub-analysis should serve as springboard to generate new hypotheses and continue to evaluate the combination of these two therapeutic tools.

Original Title: Clinical Relevance of Discordance Between Physiology-and Imaging Guided PCI Strategies in Intermediate Coronary Stenosis.

Reference: Jinlong Zhang,MD,PHD et al JACC Cardiovasc Interv 2024. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...